26 August 2020 – MPA Webinar Series

Event #1 – Wed 26th August from 7pm to 830pm Topics: Dermatology and Melanoma Surgery Please register via the Eventbrite link: https://www.eventbrite.com.au/e/dermatology-and-melanoma-surgery-a-discussion-with-our-specialists-registration-116189932215?aff=ebdssbeac >> DOWNLOAD PDF for full details

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Townsville’s First Ever Twilight Melanoma March

She will next month join Townsville’s first ever twilight Melanoma March in honour of her mother, Gina Sellen, who lost her battle against the deadly cancer in 2016.

Cancer in the News

Feature Articles

Imaging matters when judging ‘risky nevi’

In the past, only clinical factors were used to judge “risky nevi,” but imaging modalities are predictive tools for identifying choroidal nevus risk factors for growth to melanoma, according to Carol L. Shields, MD.


Posted in Melanoma News, Health Professionals, Of Interest

Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey

BACKGROUND: The COVID-19 pandemic imposes major challenges for care of cancer patients.


Posted in Melanoma News, Health Professionals, Of Interest

A Phase IB Study of Belvarafenib Alone and in Combination with Cobimetinib in People with Advanced Melanoma Who Had Immunotherapy

The purpose of this study is to find the highest dose of the investigational drug belvarafenib that can be given safely alone and with cobimetinib in people with advanced NRAS-mutated melanoma that continues to grow despite prior treatment with immunotherapy.


Posted in Melanoma News, Health Professionals, Clinical Trials

New Insights about Melanocytes Could Lead to More Targeted Melanoma Treatments

Newswise — SALT LAKE CITY – Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) have generated the first “atlas” of human melanocytes located throughout the body.


Posted in Melanoma News, Health Professionals, Of Interest